🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Gabriel Figueroa‐Parra

ORCID: 0000-0002-6077-8899

Also affiliated with University of New Mexico Hospital, Universidad Autónoma de Nuevo León, WinnMed, Mayo Clinic in Arizona, Hospital Universitario Dr José Eleuterio Gonzalez, Mayo Clinic in Florida

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 6%percentile

0.265Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Utilisation of cardiovascular preventive services in a rheumatoid arthritis population-based cohort

RMD Open(2023)10.1136/rmdopen-2023-003318

Top 59%

0.265DataRank

Top 59%3 citations

Cassondra A. Hulshizer, Elena Myasoedova, John M. Davis, Andrew C. Hanson, Alí Duarte‐García +4 more

Papers

Driven by 13 papers — median percentile 41. Top paper: “Clinical presentation and outcomes in patients with antiphospholipid syndrome-associated adrenal hemorrhage. A multicenter cohort study and systematic literature review”.

Clinical presentation and outcomes in patients with antiphospholipid syndrome-associated adrenal hemorrhage. A multicenter cohort study and systematic literature review

Clinical Immunology(2024)10.1016/j.clim.2024.109906

N/A

0.330DataRank · unranked

8 citations

Gabriel Figueroa‐Parra, Jeffrey X. Yang, Hannah E. Langenfeld, Mariana González‐Treviño, Prerna Dogra +8 more

Utilisation of cardiovascular preventive services in a rheumatoid arthritis population-based cohort

RMD Open(2023)10.1136/rmdopen-2023-003318

Top 59%

0.265DataRank

Top 59%3 citations

Cassondra A. Hulshizer, Elena Myasoedova, John M. Davis, Andrew C. Hanson, Alí Duarte‐García +4 more

COVID-19 Vaccine Uptake Among Patients With Systemic Lupus Erythematosus in the American Midwest: The Lupus Midwest Network (LUMEN)

The Journal of Rheumatology(2022)10.3899/jrheum.220220

N/A

0DataRank · unranked

7 citations

Gabriel Figueroa‐Parra, Jeffrey X. Yang, Cassondra A. Hulshizer, Tina M. Gunderson, Stephanie Q. Duong +5 more

Health Care Utilization in Systemic Lupus Erythematosus in the Community

JCR Journal of Clinical Rheumatology(2022)10.1097/rhu.0000000000001899

N/A

0DataRank · unranked

3 citations

Gabriel Figueroa‐Parra, Maria O Valenzuela-Almada, Mehmet Hocaoǧlu, Sebastián Vallejo, Shirley‐Ann Osei‐Onomah +9 more

Multimorbidity in systemic lupus erythematosus in a population-based cohort: the Lupus Midwest Network

Lara D. Veeken(2023)10.1093/rheumatology/kead617

N/A

0DataRank · unranked

14 citations

José A. Meade‐Aguilar, Cassondra A. Hulshizer, Tina M. Gunderson, Alanna M. Chamberlain, Uma Thanarajasingam +5 more

Immune responses and disease biomarker long-term changes following COVID-19 mRNA vaccination in a cohort of rheumatic disease patients

Frontiers in Immunology(2023)10.3389/fimmu.2023.1224702

N/A

0DataRank · unranked

10 citations

Gabriel Figueroa‐Parra, Xian Zhou, Yanfeng Li, Jane Jaquith, Kathleen McCarthy-Fruin +11 more

Clinical features, risk factors, and outcomes of diffuse alveolar hemorrhage in antiphospholipid syndrome: A mixed-method approach combining a multicenter cohort with a systematic literature review

Clinical Immunology(2023)10.1016/j.clim.2023.109775

N/A

0DataRank · unranked

10 citations

José A. Meade‐Aguilar, Hannah E. Langenfeld, Mariana González‐Treviño, Mehmet Hocaoǧlu, Andrew C. Hanson +8 more

Immune responses and disease biomarker long-term changes following COVID-19 mRNA vaccination in a cohort of rheumatic disease patients

medRxiv(2023)10.1101/2023.03.22.23287597

N/A

0DataRank · unranked

1 citations

Xian Zhou, Yanfeng Li, Jane Jaquith, Kathleen McCarthy-Fruin, Jennifer Sletten +11 more

Fragility of randomised controlled trials for systemic lupus erythematosus and lupus nephritis therapies

Lupus Science & Medicine(2024)10.1136/lupus-2023-001068

N/A

0DataRank · unranked

8 citations

Michael Putman, Cynthia S. Crowson, Alí Duarte‐García, Gabriel Figueroa‐Parra

Treatment trends of systemic lupus erythematosus from 2007 to 2023 in the USA

Lupus Science & Medicine(2024)10.1136/lupus-2024-001317

N/A

0DataRank · unranked

8 citations

Herbert C. Heien, Kenneth J. Warrington, Nilay D. Shah, Cynthia S. Crowson, Rozalina G. McCoy +2 more

Long-Term Opioid Therapy Among Patients With Systemic Lupus Erythematosus in the Community: A Lupus Midwest Network (LUMEN) Study

The Journal of Rheumatology(2022)10.3899/jrheum.220822

N/A

0DataRank · unranked

11 citations

Molly M. Jeffery, Jesse Y. Dabit, Baptiste Chevet, Maria O Valenzuela-Almada, Mehmet Hocaoǧlu +9 more

Association between antiphospholipid antibodies and diffuse alveolar haemorrhage risk in systemic lupus erythematosus: a systematic review and meta-analysis

Lara D. Veeken(2024)10.1093/rheumatology/keae632

N/A

0DataRank · unranked

2 citations

Gabriel Figueroa‐Parra, Jeffrey X. Yang, Larry J. Prokop, Sherif M. Gamal, Mercedes García +10 more

Soluble LILRA3 is aberrantly expressed in antiphospholipid syndrome (APS) and is a potential marker of thrombotic APS

Lara D. Veeken(2022)10.1093/rheumatology/keac192

N/A

0DataRank · unranked

5 citations

Chun Li, Hui Shi, Yixue Guo, Yundi Tang, Chen Chen +10 more